Características biológicas das células-tronco mesenquimais

SP Bydlowski, AA Debes, LMF Maselli… - Revista Brasileira de …, 2009 - SciELO Brasil
Células-tronco são células indiferenciadas. Como tal, apresentam uma série de
características que as tornam candidatas à utilização terapêutica. As principais …

Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells

G Pasquinelli, PL Tazzari, C Vaselli, L Foroni… - Stem Cells, 2007 - academic.oup.com
The clinical use of endothelial progenitor cells is hampered by difficulties in obtaining an
adequate number of functional progenitors. This study aimed to establish whether human …

Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers

MI Macias, J Grande, A Moreno, I Domínguez… - American journal of …, 2010 - Elsevier
OBJECTIVE: The objective of the study was to isolate and characterize a population of
mesenchymal stem cells (MSCs) from human term placental membranes. STUDY DESIGN …

Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion

M Witkowska-Zimny, E Wrobel - Cellular and Molecular Biology …, 2011 - degruyter.com
Recently, stem cell biology has become an interesting topic, especially in the context of
treating diseases and injuries using transplantation therapy. Several varieties of human …

Placenta as a reservoir of stem cells: an underutilized resource?

C Pipino, P Shangaris, E Resca, S Zia… - British medical …, 2013 - search.ebscohost.com
Introduction Both embryonic and adult tissues are sources of stem cells with therapeutic
potential but with some limitations in the clinical practice such as ethical considerations …

Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives

R Vawda, MG Fehlings - Current stem cell research & therapy, 2013 - ingentaconnect.com
Nearly 1.5 million people in the US live with a spinal cord injury (SCI). The cost to the
healthcare system is estimated at over $10 billion annually likely because over 65% of SCIs …

Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro

H Karlsson, T Erkers, S Nava, S Ruhm… - Clinical & …, 2012 - academic.oup.com
Bone marrow-derived mesenchymal stromal cells (BM-MSCs) have immunosuppressive
properties and have been used to treat steroid-refractory acute graft-versus-host disease …

Angiogenic potential of human dental pulp stromal (stem) cells

C Marchionni, L Bonsi, F Alviano… - International journal …, 2009 - journals.sagepub.com
Dental pulp is a heterogeneous microenviroment where unipotent progenitor and pluripotent
mesenchymal stem cells cohabit. In this study we investigated whether human Dental Pulp …

Making more womb: clinical perspectives supporting the development and utilization of mesenchymal stem cell therapy for endometrial regeneration and infertility

M Strug, L Aghajanova - Journal of Personalized Medicine, 2021 - mdpi.com
The uterus is a homeostatic organ, unwavering in the setting of monthly endometrial
turnover, placental invasion, and parturition. In response to ovarian steroid hormones, the …

Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model

T Mirabella, M Cilli, S Carlone, R Cancedda, C Gentili - Biomaterials, 2011 - Elsevier
Most urgent health problems are related to a blood vessel formation failure. The use of stem
cells from different sources or species for both in vitro and in vivo engineering of …